4.6 Article

Suppression of estrogen receptor-alpha transactivation by thyroid transcription factor-2 in breast cancer cells

Journal

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2012.04.039

Keywords

Estrogen receptor; Thyroid transcription factor-2; Coregulator; Breast cancer; Cell proliferation

Funding

  1. Ministry of Health & Welfare, Republic of Korea [A100304]
  2. Korea Health Promotion Institute [A100304] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

Estrogen receptors (ERs), which mediate estrogen actions, regulate cell growth and differentiation of a variety of normal tissues and hormone-responsive tumors through interaction with cellular factors. In this study, we show that thyroid transcription factor-2 (TTF-2) is expressed in mammary gland and acts as ER alpha co-repressor. TTF-2 inhibited ER alpha transactivation in a dose-dependent manner in MCF-7 breast cancer cells. In addition, TTF-2 directly bound to and formed a complex with ER alpha, colocalizing with ER alpha in the nucleus. In MCF-7/TTF-2 stable cell lines, TTF-2 repressed the expression of endogenous ER alpha target genes such as pS2 and cyclin D1 by interrupting ER alpha binding to target promoters and also significantly decreased cell proliferation. Taken together, these data suggest that TTF-2 may modulate the function of ER alpha as a corepressor and play a role in ER-dependent proliferation of mammary cells. (C) 2012 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available